Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Nasal Mesenchymal Exosome Administration on Vision Function in CVI

NCT07492966 is registered in ClinicalTrials.gov with Hatice Semrin Timlioglu İper as lead sponsor.

NCT NCT07492966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07492966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Nasal Mesenchymal Exosome Administration on Vision Function in CVI
Lead sponsor
Hatice Semrin Timlioglu İper
Phase
Observational
Overall status
Completed
Start date
June 30, 2024
Completion date
September 24, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cortical visual impairment, visual function